Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
457 |
|
| Actual shortage: | 22 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 429 (94%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 9 (13%) | |
| Discontinued: | 58 (84%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
19 (61%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROXYZINE | 50MG | CAPSULE | Resolved | 2019-11-08 | 2019-12-06 | 98246 |
| HYDROXYZINE | 50MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-23 | 160167 |
| HYDROXYZINE | 50MG | CAPSULE | Avoided shortage | 2022-08-11 | 2022-09-30 | 166474 |
| HYDROXYZINE | 50MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-23 | 176660 |
| HYDROXYZINE | 50MG | CAPSULE | Resolved | 2023-06-29 | 2023-08-14 | 196837 |
| HYDROXYZINE | 25MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-05 | 84186 |
| HYDROXYZINE | 25MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-11 | 160164 |
| HYDROXYZINE | 25MG | CAPSULE | Resolved | 2022-08-11 | 2022-09-30 | 166471 |
| HYDROXYZINE | 25MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-13 | 176637 |
| HYDROXYZINE | 10MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-05 | 84183 |
| HYDROXYZINE | 10MG | CAPSULE | Resolved | 2022-05-27 | 2023-01-31 | 161406 |
| HYDROXYZINE | 10MG | CAPSULE | Resolved | 2023-03-08 | 2023-06-13 | 186480 |
| HYDROXYZINE | 10MG | CAPSULE | Resolved | 2023-09-27 | 2023-11-15 | 205344 |
| IMIPRAMINE | 25MG | TABLET | Resolved | 2021-02-03 | 2021-03-11 | 133186 |
| IMIPRAMINE | 50MG | TABLET | Resolved | 2017-03-24 | 2017-03-28 | 4140 |
| IPRAVENT | 0.03% | SOLUTION | Resolved | 2017-03-14 | 2020-08-06 | 2199 |
| IPRAVENT | 0.06% | SOLUTION | Resolved | 2019-06-05 | 2019-08-22 | 85654 |
| IPRAVENT | 42MCG | SOLUTION | Resolved | 2022-12-02 | 2022-12-29 | 177045 |
| IPRAVENT | 42MCG | SOLUTION | Resolved | 2023-03-08 | 2023-03-31 | 186512 |
| IPRAVENT | 42MCG | SOLUTION | Resolved | 2023-10-05 | 2023-11-01 | 206273 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DOXEPIN | 100MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65447 |
| DOXEPIN | 10MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65452 |
| DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| DOXEPIN | 75MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65466 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |